Bristol Myers Squibb stock tumbled Thursday on a light outlook for 2025 following a strong fourth-quarter report.
Gevo (NASDAQ:GEVO – Get Free Report)‘s stock had its “buy” rating reissued by research analysts at HC Wainwright in a research note issued to investors on Tuesday,Benzinga reports. They presently have ...
Palantir Technologies (NASDAQ:PLTR – Get Free Report) had its price objective increased by research analysts at DA Davidson from $47.00 to $105.00 in a note issued to investors on Tuesday,Benzinga ...
Investors and other persons interested in learning more about the virtual investor presentation can find information and registration details at the following link: About Gevo Gevo is a ...
The blue-chip index, up 0.6%, was heading for its second consecutive gain this week. The Dow was riding higher on gains in ...